» Articles » PMID: 36187646

Persistently High Incidence Rates of Childhood Acute Leukemias from 2010 to 2017 in Mexico City: A Population Study from the MIGICCL

Abstract

Introduction: Over the years, the Hispanic population living in the United States has consistently shown high incidence rates of childhood acute leukemias (AL). Similarly, high AL incidence was previously observed in Mexico City (MC). Here, we estimated the AL incidence rates among children under 15 years of age in MC during the period 2010-2017.

Methods: The Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia conducted a study gathering clinical and epidemiological information regarding children newly diagnosed with AL at public health institutions of MC. Crude age incidence rates (cAIR) were obtained. Age-standardized incidence rates worldwide (ASIRw) and by municipalities (ASIRm) were calculated by the direct and indirect methods, respectively. These were reported per million population <15 years of age; stratified by age group, sex, AL subtypes, immunophenotype and gene rearrangements.

Results: A total of 903 AL cases were registered. The ASIRw was 63.3 (cases per million) for AL, 53.1 for acute lymphoblastic leukemia (ALL), and 9.4 for acute myeloblastic leukemia. The highest cAIR for AL was observed in the age group between 1 and 4 years (male: 102.34 and female: 82.73). By immunophenotype, the ASIRw was 47.3 for B-cell and 3.7 for T-cell. The incidence did not show any significant trends during the study period. The ASIRm for ALL were 68.6, 66.6 and 62.8 at Iztacalco, Venustiano Carranza and Benito Juárez, respectively, whereas, other municipalities exhibited null values mainly for AML.

Conclusion: The ASIRw for childhood AL in MC is among the highest reported worldwide. We observed spatial heterogeneity of rates by municipalities. The elevated AL incidence observed in Mexican children may be explained by a combination of genetic background and exposure to environmental risk factors.

Citing Articles

Early Infection Incidence and Risk of Acute Leukemia Development Among Mexican Children.

Sepulveda-Robles O, Flores-Lujano J, Nunez-Enriquez J, Jimenez-Hernandez E, Duarte-Rodriguez D, Martin-Trejo J Cancers (Basel). 2025; 17(5).

PMID: 40075581 PMC: 11899646. DOI: 10.3390/cancers17050733.


Tumor-Suppressive Cross-Linking of Anti- Antibodies in Acute Lymphoblastic Leukemia.

Maravelez Acosta V, Crisostomo Vazquez M, Eligio Garcia L, Franco Sandoval L, Castro Perez D, Patino Lopez G Int J Mol Sci. 2024; 25(15).

PMID: 39125875 PMC: 11313589. DOI: 10.3390/ijms25158307.


Leukemia Types and Subtypes Analysis: Epidemiological Age-Standardized Exploration in the Mexican Bajio Region.

Romero-Morelos P, Gonzalez-Yebra A, Bueno-Rosario L, Gonzalez-Yebra B Medicina (Kaunas). 2024; 60(5).

PMID: 38792914 PMC: 11123364. DOI: 10.3390/medicina60050731.


is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.

Garcia-Solorio J, Nunez-Enriquez J, Jimenez-Olivares M, Flores-Lujano J, Flores-Espino F, Molina-Garay C Front Oncol. 2024; 14:1337954.

PMID: 38634053 PMC: 11022689. DOI: 10.3389/fonc.2024.1337954.


Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy.

Nunez-Enriquez J, Romo-Rodriguez R, Gaspar-Mendoza P, Zamora-Herrera G, Torres-Pineda L, Amador-Cardoso J Front Oncol. 2024; 14:1304690.

PMID: 38634051 PMC: 11022691. DOI: 10.3389/fonc.2024.1304690.


References
1.
Lee S, Antillon-Klussmann F, Pei D, Yang W, Roberts K, Li Z . Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia. JAMA Oncol. 2022; 8(3):354-363. PMC: 8796058. DOI: 10.1001/jamaoncol.2021.6826. View

2.
Jimenez-Morales S, Miranda-Peralta E, Saldana-Alvarez Y, Perez-Vera P, Paredes-Aguilera R, Rivera-Luna R . BCR-ABL, ETV6-RUNX1 and E2A-PBX1: prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients. Leuk Res. 2008; 32(10):1518-22. DOI: 10.1016/j.leukres.2008.03.021. View

3.
Glazer E, Perkins C, Young Jr J, Schlag R, Campleman S, Wright W . Cancer among Hispanic children in California, 1988-1994: comparison with non-Hispanic white children. Cancer. 1999; 86(6):1070-9. View

4.
Pui C, Sandlund J, Pei D, Rivera G, Howard S, Ribeiro R . Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA. 2003; 290(15):2001-7. DOI: 10.1001/jama.290.15.2001. View

5.
Perez-Saldivar M, Fajardo-Gutierrez A, Bernaldez-Rios R, Martinez-Avalos A, Medina-Sanson A, Espinosa-Hernandez L . Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer. 2011; 11:355. PMC: 3171387. DOI: 10.1186/1471-2407-11-355. View